Compare BUR & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BUR | AZTA |
|---|---|---|
| Founded | 2009 | 1978 |
| Country | Guernsey | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Industrial Machinery/Components |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.6B |
| IPO Year | 2010 | 1995 |
| Metric | BUR | AZTA |
|---|---|---|
| Price | $9.50 | $39.03 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $18.00 | ★ $43.20 |
| AVG Volume (30 Days) | ★ 1.5M | 595.4K |
| Earning Date | 03-02-2026 | 02-04-2026 |
| Dividend Yield | ★ 1.29% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.40 | N/A |
| Revenue | $466,134,000.00 | ★ $593,821,000.00 |
| Revenue This Year | $13.60 | $6.18 |
| Revenue Next Year | $10.53 | $5.24 |
| P/E Ratio | $24.46 | ★ N/A |
| Revenue Growth | N/A | ★ 3.55 |
| 52 Week Low | $8.19 | $23.91 |
| 52 Week High | $15.73 | $55.64 |
| Indicator | BUR | AZTA |
|---|---|---|
| Relative Strength Index (RSI) | 52.73 | 67.94 |
| Support Level | $9.14 | $37.05 |
| Resistance Level | $9.96 | $40.28 |
| Average True Range (ATR) | 0.24 | 1.17 |
| MACD | 0.06 | 0.35 |
| Stochastic Oscillator | 61.69 | 87.60 |
Burford Capital Ltd is a finance firm providing litigation finance, insurance, and risk transfer, law firm lending, corporate intelligence and judgment enforcement, and a wide range of investment activities. It operates in two segments: Principal Finance, which allocates capital to legal finance assets from its balance sheet, primarily as capital provision assets and in limited scope through interests in private funds managed by the company; Asset management and other services, which includes the provision of services to the legal industry, including litigation insurance; and other corporate. The geographical segments include the United States, United Kingdom, Singapore, Hong Kong, China, and, Australia.
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.